Novel quinoxaline compound against extended-spectrum beta-lactamases producing bacteria.

Autor: Alkuwaity K; Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia. aegmusa@kau.edu.sa., Mokhtar JA, Abujamel T, Attallah D, Altorki TA, Alsieni M, Bazuhair MA, Helmi NR, AbdulMajed H, Juma NA, Abdullah H, Al-Rabia MW, Ibrahem K, Alfadil A

Publikováno v: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2024 May; Vol. 28 (10), pp. 3548-3555.